$KALV #Stocks #StockMarket #KalvistaPharmaceuticals reported Q3 EPS on https://t.co/savSNTKlN1: KALV reported disastrous Q3, where Sales faded by -59.46 % to $1.577 MM and loss per share has widen to $-0.52, from the same quarter a year ago. https://t.co/qFSR3eVtAo